Outcome of Therapies for Membranous Glomerulonephritis During Three Waves of COVID Pandemic
Copyright: © 2023 Indian Journal of Nephrology..
There is lack of clarity on immunosuppressive therapy in glomerular diseases and concomitant corona-virus infection. We retrospectively evaluated 36 patients with primary membranous nephropathy from January 2020 to December 2021 who had received immunosuppression during this period. Diagnosis of COVID-19 was made based on self-reported history of being COVID positive. History of hospitalization and oxygen therapy was noted. Four patients developed COVID-19 in this cohort, and all were infected only once. Two patients had asymptomatic disease and two were hospitalized for severe COVID-19 and had complete recovery. In immunocompromised patients, there is a high risk of infection. This observational study is an attempt to bridge the gap that immunosuppression can precipitate COVID-19 infection.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:33 |
|---|---|
| Enthalten in: |
Indian journal of nephrology - 33(2023), 4 vom: 19. Juli, Seite 289-291 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kumar, Asheesh [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Journal Article |
|---|
| Anmerkungen: |
Date Revised 31.10.2023 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.4103/ijn.ijn_162_22 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM362774064 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM362774064 | ||
| 003 | DE-627 | ||
| 005 | 20231226091936.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4103/ijn.ijn_162_22 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1209.xml |
| 035 | |a (DE-627)NLM362774064 | ||
| 035 | |a (NLM)37781551 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kumar, Asheesh |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Outcome of Therapies for Membranous Glomerulonephritis During Three Waves of COVID Pandemic |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 31.10.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright: © 2023 Indian Journal of Nephrology. | ||
| 520 | |a There is lack of clarity on immunosuppressive therapy in glomerular diseases and concomitant corona-virus infection. We retrospectively evaluated 36 patients with primary membranous nephropathy from January 2020 to December 2021 who had received immunosuppression during this period. Diagnosis of COVID-19 was made based on self-reported history of being COVID positive. History of hospitalization and oxygen therapy was noted. Four patients developed COVID-19 in this cohort, and all were infected only once. Two patients had asymptomatic disease and two were hospitalized for severe COVID-19 and had complete recovery. In immunocompromised patients, there is a high risk of infection. This observational study is an attempt to bridge the gap that immunosuppression can precipitate COVID-19 infection | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Primary membranous nephropathy | |
| 650 | 4 | |a Rituximab | |
| 650 | 4 | |a Serum PLA2R | |
| 700 | 1 | |a Singh, Ram |e verfasserin |4 aut | |
| 700 | 1 | |a Chauhan, Ashish |e verfasserin |4 aut | |
| 700 | 1 | |a Sharma, Dheeraj |e verfasserin |4 aut | |
| 700 | 1 | |a Sandal, Rajeev |e verfasserin |4 aut | |
| 700 | 1 | |a Chauhan, Naresh |e verfasserin |4 aut | |
| 700 | 1 | |a Gupta, Samriti |e verfasserin |4 aut | |
| 700 | 1 | |a Verma, Balbir |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Indian journal of nephrology |d 1996 |g 33(2023), 4 vom: 19. Juli, Seite 289-291 |w (DE-627)NLM088814432 |x 0971-4065 |7 nnns |
| 773 | 1 | 8 | |g volume:33 |g year:2023 |g number:4 |g day:19 |g month:07 |g pages:289-291 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4103/ijn.ijn_162_22 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 33 |j 2023 |e 4 |b 19 |c 07 |h 289-291 | ||